drugset

drugset / Trial / NCT02767999

Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke

NCT02767999 ↗

Phase 4 Completed 25 enrolled University Hospital, Toulouse

RandomizedParallel-groupDouble-blindTreatment

Summary

Fluoxetine action on cerebral connectivity changes in acute ischemic stroke patients

Timeline

Start: 2017-02-27
Primary completion: 2022-01-31
Completion: 2022-01-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fluoxetine	Small molecule	20 mg	—

Indications